<DOC>
	<DOCNO>NCT00002781</DOCNO>
	<brief_summary>RATIONALE : Boron neutron capture therapy may selectively kill tumor cell without harm normal tissue . PURPOSE : Phase I trial study effectiveness boron neuron capture therapy treat patient stage III melanoma .</brief_summary>
	<brief_title>Boron Neutron Capture Therapy Treating Patients With Stage III Melanoma</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate maximum tolerate dose neutron irradiation give combination borophenylalanine-fructose complex ( BPA-F ) patient stage III melanoma . II . Evaluate safety regimen . III . Evaluate tumor response regimen . OUTLINE : This dose-finding study . Patients receive test dose borophenylalanine-fructose complex ( BPA-F ) biodistribution study undergo punch biopses tumor normal tissue measure B-10 concentration . Later , treatment dose BPA-F 1 hour follow neutron irradiation . Groups 3 patient receive escalated dos neutron irradiation maximum tolerate dose determine . Patients complete protocol treatment continue meet eligibility criterion may re-enter study , provide least 6 month elapse since completion prior therapy field boundary new irradiation site seperated boundary previously irradiate site . Patients follow monthly 12 month , every 3-6 month need . PROJECTED ACCRUAL : Approximately 15 patient enter .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven melanoma clinical stage III Estimated clinical tumor depth 1.06.0 cm epidermis Tumor surface diameter great 10 cm Grossly evident cutaneous subcutaneous tumor nodule eligible irradiation PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70 % 100 % Life expectancy : More 3 month Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No history phenylketonuria Negative serum pregnancy test require fertile woman Adequate contraception require fertile woman 6 month study PRIOR CONCURRENT THERAPY : No prior radiotherapy target area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2000</verification_date>
	<keyword>stage III melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>